What Is Genprex, Inc. (GNPX) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Genprex, Inc. is potentially undervalued at its current price of $0.49. Based on our 13-model framework, Genprex, Inc.'s intrinsic value is estimated at a composite fair value of $1.48 — representing +201.3% implied upside — with 5 out of 6 active models confirming this thesis. Model dispersion is worth noting: First Chicago targets $2.83 (+477.1%), versus ML-RIV at $0.06 (-88.5%). This +565.5% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About GNPX?
6 of 13 models are currently active for GNPX. Of these, 5 models suggest upside while 1 model suggests overvaluation. The Bayesian DCF estimates GNPX's intrinsic value at $1.16, implying +135.6% upside from the current price. See which stocks rank higher →
How Does GNPX Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, GNPX ranks #361 by Quality of Company score. CirclFi's QOC score of 3.7/10 evaluates 32 fundamental signals. A score of 3.7 signals below-average fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
As a biopharma enterprise, Genprex, Inc. operates in a sector where clinical trial success rate is a critical driver of valuation. Investors evaluating GNPX should weigh these sector-specific dynamics alongside our model-derived fair values.
Is GNPX a Value Trap?
CirclFi's Value Trap algorithm assigns GNPX a score of 39/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
6 of 13 models are active for Genprex, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Genprex, Inc.'s fundamental quality profile registers 3.7/10. This mixed score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +565.5% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every GNPX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across GNPX's 6 active models, average confidence is 21%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad